The effect of phospholipids on the formation of immune complexes between autoantibodies and beta2-glycoprotein I or prothrombin

Clinical Immunology : the Official Journal of the Clinical Immunology Society
E M BeversG M Willems

Abstract

In the last decennium, it became clear that antiphospholipid antibodies found in patients with antiphospholipid syndrome (APS) are in fact antibodies against lipid-bound plasma proteins. The most frequently occurring antigens are beta2-glycoprotein I and prothrombin, although several other lipid-bound plasma proteins have been reported as antigen for antiphospholipid antibodies. Both proteins bind to anionic phospholipids, mainly phosphatidylserine, which becomes exposed at the surface of activated platelets, apoptotic cells, or cell-derived microparticles. The binding of beta2-glycoprotein I and prothrombin to these cell surfaces or to artificial lipid vesicles with comparable amounts of anionic phospholipids is rather weak. Antiphospholipid antibodies from patients are predominantly of low affinity regarding their interaction with beta2-glycoprotein I or prothrombin in solution. In the presence of a suitable phospholipid surface, however, this interaction is strongly enhanced. There is now strong evidence that formation of bivalent, trimolecular immune complexes at the lipid membrane essentially contributes to the binding of these intrinsically low affinity patient antibodies. Depending on the affinity, the epitope specificit...Continue Reading

References

Oct 29, 1979·Biochemical and Biophysical Research Communications·E Polz, G M Kostner
Feb 1, 1992·Lupus·L R SammaritanoA E Gharavi
Jul 15, 1991·The Biochemical Journal·A SteinkassererA J Day
Dec 1, 1991·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·J M FreyssinetM L Wiesel
Oct 25, 1991·Journal of Immunological Methods·J ArvieuxM G Colomb
Sep 1, 1990·British Journal of Haematology·R G MaliaF E Preston
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H P McNeilS A Krilis
Jun 1, 1989·The Biochemical Journal·A GriesT Kenner
Oct 29, 1986·Biochimica Et Biophysica Acta·J NimpfR F Zwaal
Jan 1, 1984·The International Journal of Biochemistry·H Wurm
Jun 5, 1984·Biochemistry·P van de WaartT Lindhout
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J LozierF W Putnam
Aug 14, 1980·Biochemical and Biophysical Research Communications·Y NakayaH B Brewer
Nov 1, 1995·Clinical and Experimental Immunology·D BorchmanO P Lamba
Aug 15, 1995·The Biochemical Journal·Z KerteszR B Sim
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J E HuntS A Krilis
Jul 31, 1998·Thrombosis Research·M GalazkaV A DeBari
Nov 7, 1998·Biochimica Et Biophysica Acta·R F ZwaalE M Bevers
Apr 8, 1999·Clinical and Experimental Immunology·L W ChamleyP M Johnson
Apr 28, 1999·Lancet·M Greaves
May 7, 1999·The Biochemical Journal·T A BrightonC N Chesterman
Aug 14, 1999·Biochimica Et Biophysica Acta·E M BeversR F Zwaal

❮ Previous
Next ❯

Citations

Jan 21, 2016·Expert Review of Hematology·Cecilia Beatrice ChighizolaPier Luigi Meroni
Jul 9, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Robert A S Roubey
Mar 15, 2006·Trends in Cell Biology·Yi WuRaymond B Birge
Aug 25, 2015·Mediators of Inflammation·Catalina BurbanoDiana Castaño
Sep 5, 2007·Molecular Immunology·Tom Eirik MollnesMichael Kirschfink
Apr 1, 2010·Lupus·T Atsumi, T Koike
Sep 21, 2006·Blood·Bill GiannakopoulosSteven A Krilis
Jun 24, 2009·International Journal of Occupational Medicine and Environmental Health·Radosław SwierczWojciech Wasowicz
Jul 1, 2009·American Journal of Hematology·Valeria RossettoPaolo Simioni
Dec 24, 2005·Transfusion Medicine Reviews·Jan Simak, Monique P Gelderman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.